NASDAQ:BBI
Delisted
Brickell Biotech Inc. Stock News
$1.94
+0 (+0%)
At Close: Feb 07, 2023
Avacta Group appoints BBI Solutions as manufacturing partner for rapid SARS-CoV-2 antigen test - DirectorsTalk
06:05am, Thursday, 06'th Aug 2020
Avacta Group plc (LON:AVCT), the developer of Affimer® biotherapeutics and reagents, has announced that it has appointed BBI Solutions, part of BBI Group, to manufacture the saliva-based rapid SARS-
Avacta Appoints COVID-19 Rapid Antigen Test Manufacturing Partner
12:00am, Thursday, 06'th Aug 2020
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has appointed BBI Solutions, part
Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020
08:05pm, Monday, 03'rd Aug 2020
BOULDER, Colo., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated pre
BBI support scored at 47 per cent in new survey
11:32am, Wednesday, 22'nd Jul 2020
NAIROBI, Kenya, Jul 22 – A new study by Research firm Intel Research Solutions (IRS) has projected the popularity of the Building Bridges Initiative (BBI) spearheaded by President Uhuru Kenyatta
Amazon CEO Jeff Bezos adds record $13 billion to his fortune in single day
06:40am, Tuesday, 21'st Jul 2020
Jeff Bezos’s net worth swelled a mammoth $74.4 billion in 2020 and his total fortune is now worth $189 billion. This despite the major economic depression caused by the coronavirus pandemic.
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
12:00am, Wednesday, 15'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
Altimmune Inc (NASDAQ: ALT...
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
Broadband Infraco adds capability to monitor WACS
12:28pm, Tuesday, 07'th Jul 2020
Analysts laud the state-owned entity’s decision to add undersea cable monitoring as part of its new service offerings.
The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes
12:00am, Wednesday, 01'st Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 30)
ADC Therapeutics SA (NYSE:...
BBI team ready to present final report
04:55pm, Tuesday, 30'th Jun 2020
NAIROBI, Kenya Jun 30 – The Building Bridges Initiative Steering Committee says it has completed its task, and is now ready to present its final report. Joint Secretaries of the Taskforce, Martin Ki
BBI team seeks term extension to complete task
08:05am, Tuesday, 30'th Jun 2020
NAIROBI, Kenya Jun 30 – The Steering Committee on the Implementation of the Building Bridges Initiative Report has sought an extension of its tenure to finalise on their report before handing it ove
Robert Elias Joins The Exclusive Haute Lawyer Network By Haute Living
03:10am, Thursday, 25'th Jun 2020
Robert Elias has joined the exclusive Haute Lawyer Network by Haute Living as an expert in Real Estate Law in South Florida.
MIAMI (PRWEB) June 24, 2020
Robert Elias, leading Real Estate Law atto
Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering
02:00am, Thursday, 18'th Jun 2020
BOULDER, Colo., June 17, 2020 -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated.
Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering
12:00am, Thursday, 18'th Jun 2020
BOULDER, Colo., June 17, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...